Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Medin

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Immunotechnology : an International Journal of Immunological Engineering|March 1, 1997
Viral vectors for gene therapy of hematopoietic cellsJ A Medin, S Karlsson
Journal of Inherited Metabolic Disease|January 5, 2002
Gene therapy for Fabry diseaseC Siatskas, J A Medin
Proceedings of the Association of American Physicians|March 1, 1997
Selection of retrovirally transduced cells to enhance the efficiency of gene therapyJ A Medin, S Karlsson
Heart Disease (Hagerstown, Md.)|December 1, 2001
Gene transfer in the cardiovascular system: update 2000J A Medin, P M Buttrick
The Journal of Biological Chemistry|March 15, 1992
Lack of functional significance of Cys227 and Cys234 in terminal deoxynucleotidyltransferaseJ A Medin, M S Coleman
Immunotherapy|October 26, 2017
Sphingolipid pathway enzymes modulate cell fate and immune responsesS Molino, E Tate, W M McKillop, et al.
Human Gene Therapy|August 31, 1999
Circulating alpha-galactosidase A derived from transduced bone marrow cells: relevance for corrective gene transfer for Fabry diseaseT Takenaka, G Qin, R O Brady, et al.
Cancer Gene Therapy|December 20, 2008
Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cellsJ C Symes, C Siatskas, D H Fowler, et al.
Expert Opinion on Biological Therapy|May 22, 2009
Novel application of lentiviral vectors towards treatment of graft-versus-host diseaseMatthew D Scaife, Anton Neschadim, D H Fowler, et al.
Cancer Gene Therapy|March 6, 2012
Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancerA Neschadim, J C M Wang, A Lavie, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Immunotechnology : an International Journal of Immunological Engineering|March 1, 1997
Viral vectors for gene therapy of hematopoietic cellsJ A Medin, S Karlsson
Journal of Inherited Metabolic Disease|January 5, 2002
Gene therapy for Fabry diseaseC Siatskas, J A Medin
Proceedings of the Association of American Physicians|March 1, 1997
Selection of retrovirally transduced cells to enhance the efficiency of gene therapyJ A Medin, S Karlsson
Heart Disease (Hagerstown, Md.)|December 1, 2001
Gene transfer in the cardiovascular system: update 2000J A Medin, P M Buttrick
The Journal of Biological Chemistry|March 15, 1992
Lack of functional significance of Cys227 and Cys234 in terminal deoxynucleotidyltransferaseJ A Medin, M S Coleman
Immunotherapy|October 26, 2017
Sphingolipid pathway enzymes modulate cell fate and immune responsesS Molino, E Tate, W M McKillop, et al.
Human Gene Therapy|August 31, 1999
Circulating alpha-galactosidase A derived from transduced bone marrow cells: relevance for corrective gene transfer for Fabry diseaseT Takenaka, G Qin, R O Brady, et al.
Cancer Gene Therapy|December 20, 2008
Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cellsJ C Symes, C Siatskas, D H Fowler, et al.
Expert Opinion on Biological Therapy|May 22, 2009
Novel application of lentiviral vectors towards treatment of graft-versus-host diseaseMatthew D Scaife, Anton Neschadim, D H Fowler, et al.
Cancer Gene Therapy|March 6, 2012
Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancerA Neschadim, J C M Wang, A Lavie, et al.
Pageof 4